全文获取类型
收费全文 | 5959篇 |
免费 | 424篇 |
国内免费 | 203篇 |
专业分类
耳鼻咽喉 | 51篇 |
儿科学 | 89篇 |
妇产科学 | 227篇 |
基础医学 | 567篇 |
口腔科学 | 26篇 |
临床医学 | 719篇 |
内科学 | 464篇 |
皮肤病学 | 15篇 |
神经病学 | 114篇 |
特种医学 | 159篇 |
外国民族医学 | 1篇 |
外科学 | 1429篇 |
综合类 | 952篇 |
预防医学 | 204篇 |
眼科学 | 111篇 |
药学 | 640篇 |
6篇 | |
中国医学 | 279篇 |
肿瘤学 | 533篇 |
出版年
2024年 | 7篇 |
2023年 | 101篇 |
2022年 | 132篇 |
2021年 | 213篇 |
2020年 | 209篇 |
2019年 | 164篇 |
2018年 | 165篇 |
2017年 | 202篇 |
2016年 | 208篇 |
2015年 | 234篇 |
2014年 | 357篇 |
2013年 | 475篇 |
2012年 | 327篇 |
2011年 | 340篇 |
2010年 | 279篇 |
2009年 | 263篇 |
2008年 | 258篇 |
2007年 | 289篇 |
2006年 | 228篇 |
2005年 | 274篇 |
2004年 | 221篇 |
2003年 | 193篇 |
2002年 | 159篇 |
2001年 | 151篇 |
2000年 | 115篇 |
1999年 | 117篇 |
1998年 | 74篇 |
1997年 | 78篇 |
1996年 | 83篇 |
1995年 | 75篇 |
1994年 | 82篇 |
1993年 | 61篇 |
1992年 | 58篇 |
1991年 | 36篇 |
1990年 | 39篇 |
1989年 | 32篇 |
1988年 | 29篇 |
1987年 | 19篇 |
1986年 | 30篇 |
1985年 | 43篇 |
1984年 | 36篇 |
1983年 | 26篇 |
1982年 | 34篇 |
1981年 | 23篇 |
1980年 | 15篇 |
1979年 | 11篇 |
1978年 | 7篇 |
1977年 | 4篇 |
1975年 | 4篇 |
1968年 | 1篇 |
排序方式: 共有6586条查询结果,搜索用时 15 毫秒
1.
目的 运用网络药理学方法及分子对接技术探讨黄芪干预腹膜纤维化的可能机制。方法 利用中药系统药理学数据库及分析平台(TCMSP)检索黄芪的主要化学成分及靶点,并补充文献报道相关药理作用的成分作为潜在活性成分。以"peritoneal fibrosis"为关键词分别在OMIM、Genecards获取目前已知的与腹膜纤维化相关的疾病靶点,后取两者的交集靶点;对交集基因通过STRING数据库与Cytoscape 3.7.2软件构建"药物-成分-靶点-疾病"网络及蛋白互作(PPI)网络并筛选核心网络。基于R软件使用Bioconductor生物信息软件对核心靶点进行GO及KEGG富集分析,最终采用AutoDock软件将主要有效成分与核心靶点进行分子对接,得出其结合能力。结果 筛选出20个黄芪活性成分及文献报道有相关药理作用4个, 457药物作用靶点,与674个腹膜纤维化病靶点取交集,得到86个共同靶点。GO功能富集分析提示黄芪拮抗腹膜纤维化主要参与了蛋白激酶B信号转导的调节、细胞对化学的应激反应、炎症反应的调节等通路; KEGG通路富集分析主要涉及调控肿瘤、磷脂酰肌醇-3-羟激酶-蛋白激酶B(PI3K-Akt)、晚期糖基化终末产物/晚期糖基化终末产物受体(AGE-RAGE)、人类巨细胞病毒感染、HIF-1信号通路等;分子对接结果显示关键靶点与活性成分具有较好的结合能力。结论 黄芪治疗腹膜纤维化的分子机制,可能与抑制炎症及氧化应激反应、调节多种信号通路等相关。 相似文献
2.
3.
目的:探讨盆腔腹膜关闭技术在腹腔镜低位直肠癌根治术应用的疗效。方法:回顾性分析2012年1月至2016年5月我院54例腹腔镜低位直肠癌根治术中行盆底腹膜关闭患者和57例未行盆底腹膜关闭患者的临床资料。结果:盆腔腹膜关闭组与盆腔腹膜未关闭组在手术时间、术中出血量、肛门排气时间、术后进食时间以及盆腔引流管拔除时间等方面差异均无统计学意义(P>0.05)。盆腔腹膜关闭组中8例患者发生短期并发症;6例患者发生中期并发症;14例患者发生远期并发症,均为肠梗阻。盆腔腹膜未关闭组中31例患者发生短期并发症,28例患者发生中期并发症,36例患者发生远期并发症。所有患者均治疗好转。Coxs回归模型分析提示,盆腔腹膜是否关闭是腹腔镜低位直肠癌根治术患者术后生存的独立指标。结论:腹腔镜Miles术中行盆底腹膜关闭安全可行,具有临床实用价值。 相似文献
4.
《European journal of surgical oncology》2021,47(11):2888-2892
IntroductionThe PRODIGE 7-trial investigated the additional value of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to cytoreductive surgery (CRS) for patients with colorectal peritoneal metastases (CPM). The results of PRODIGE 7 were presented at the 2018 ASCO meeting showing that 30 min oxaliplatin-based HIPEC did not improve overall survival. The current study investigated the impact of PRODIGE 7 on the worldwide practice of CRS and HIPEC.Materials and methodsCRS-HIPEC experts from 19 countries were invited through the Peritoneal Surface Oncology Group International (PSOGI) to complete an online survey concerning the current CRS-HIPEC practice in their hospital and country, and were asked to appraise the effect of PRODIGE 7.ResultsThe survey was completed by 18/19 experts. Although their personal opinions of CRS-HIPEC were barely influenced by PRODIGE 7, they reported a substantial impact on daily practice. This included a switch towards Mitomycin-C based HIPEC-regimens and prolongation of HIPEC perfusion time, a reduction in the number of referrals from non-HIPEC centers, a reduction in national consensus, the removal of HIPEC from national guidelines, and a reduced reimbursement rate.ConclusionThe PRODIGE 7 has had a major impact on the practice of CRS-HIPEC for CPM worldwide. HIPEC remains an attractive option with potential for control and eradication of disease and further studies into the optimal HIPEC-regimen are urgently needed. Meanwhile, given the complexity of the treatment of patients with CPM, and the proven benefits of optimal CRS, referral of patients with potentially resectable CPM to expert centers is recommended whilst the precise role of HIPEC is further evaluated. 相似文献
5.
目的:探讨改进Seldinger法经皮穿刺腹膜透析置管术在终末期肾病患者中的应用效果。方法:选取2019年12月~2020年12月于本院进行腹膜透析置管术的终末期肾病患者61例,随机分为观察组(31例)和对照组(30例),对照组患者采用常规开腹手术置管,观察组采用改进Seldinger法置管,比较两组患者完成置管手术的相关指标(手术时间、术后排气时间、切口长度、住院时间),术后3d、1个月患者并发症发生情况。结果:较对照组,观察组手术时间、术后排气时间均更短,腹部切口长度更短(P<0.05),两组患者住院时间比较(P>0.05),观察组穿刺成功率明显高于对照组(100.00%,80.00%,χ2=6.88,P=0.01)。较对照组,观察组患者术后3d并发症发生率明显低于对照组(22.58%,50.00%,χ2=4.97,P=0.03),观察组患者术后1个月并发症发生率明显低于对照组(19.35%,53.33%,χ2=7.05,P=0.01)。结论:对终末期肾病患者运用改进Seldinger法经皮穿刺腹膜透析置管术进行置管可有效缩短手术时间和术后排气时间,创口较小,患者术后早期、远期并发症较少,临床应用效果较好。 相似文献
6.
目的探讨双线悬吊法经腹腔入路腹腔镜下肾盂成形术的临床价值。
方法2016年9月至2018年11月在连云港市第一人民医院采取双线悬吊法经腹腔入路腹腔镜下肾盂成形术患者22例,其中男19例,女3例。年龄4个月~14岁,平均年龄(5.3±2.7)岁。左侧20例,右侧1例,双侧1例,共23侧。右侧经结肠肝曲系膜缘打开侧腹膜入路,左侧经结肠系膜入路,在术中将输尿管和肾盂切口的两端用双线悬吊于腹壁,以便于缝合,用5-0可吸收线行Anderson-Hynes肾盂输尿管成形术,并从吻合口留置双J管,术后结合超声检查随访。
结果22例顺利完成手术,无中转开腹手术者。手术时间90~260 min,单侧平均(137±55)min。术中失血5~20 ml。平均住院时间7 d。术后1例因返流反复发热,在拔出双J管后症状消失,1例发生尿外渗,保留腹腔引流3 d后自愈。术后随访6~25个月,患儿临床症状消失,复查超声提示肾积水消失或减少,肾皮质逐渐增厚。
结论双线悬吊法经腹腹腔镜下肾盂成形术是一种安全、有效、容易学习的手术方法。 相似文献
7.
Rachel M. Lee MD MS Kenneth Cardona MD Maria C. Russell MD 《Journal of surgical oncology》2019,119(5):549-563
Colorectal cancer is the third most commonly diagnosed cancer in the United States. While screening methods strive to improve rates of early stage detection, 25% of patients have metastatic disease at the time of diagnosis, with the most common sites being the liver, lung, and peritoneum. While once perceived as hopeless, the last two decades have seen substantial strides in the medical, surgical, and regional therapies to treat metastatic disease offering significant improvements in survival. 相似文献
8.
《European journal of surgical oncology》2019,45(12):2310-2315
IntroductionTraditionally patients with colorectal peritoneal metastases (CRPM) were offered palliative chemotherapy and best supportive care. With the introduction of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), patients in the UK have been referred to nationally approved centres. This study describes the pattern of referral and outcomes of patients managed through one UK centre.Methodsand Methods: A prospective register recorded referrals, demographics, prior treatment pathways, and specialist multidisciplinary team (MDT) decisions (2002-2015). Peritoneal cancer index (PCI) was recorded intra-operatively; complete cytoreduction was deemed when a CC0/1 was achieved. Complications were classified using NCI CTCAE. v.4. Median overall survivals (OS) were described for those treated by CRS/HIPEC and in derived estimates for patients with isolated peritoneal metastases treated by chemotherapy alone in the ARCAD trials consortium.ResultsTwo-hundred-eighty-six patients with CRPM were referred. Despite increasing numbers of referrals annually, the proportion of patients selected for CRS/HIPEC decreased from 64.5%, to 40%, and to 37.1% for 2002–09, 2010–12, and 2013–15, respectively (p < 0.017). CRS/HIPEC was undertaken in 117 patients with a median PCI of 7 and CC0/1 achieved in 86.3%. NCI CTCAE grade 3/4 complication rates were 9.4%; 30-day mortality was 0.85%. Median OS following CRS/HIPEC was 46.0 months: that for patients not receiving CRS/HIPEC was 13.2 months.ConclusionThe evolution of the national peritoneal treatment centre over 14 years has been associated with increased referral numbers, refinement of selection for major surgery, matched with achievements of low complication rates and survival advantages in selected patients compared with traditional non-surgical treatments. 相似文献
9.
Jae Hwang Song Chan Kang Deuk Soo Hwang Dong Hun Kang Yong Hwan Kim 《Foot and Ankle Surgery》2019,25(6):748-754
BackgroundThe purpose of this study was to investigate and compare the clinical outcomes of dorsal suspension with those of neurectomy for the treatment of Morton’s neuroma.MethodsWe conducted a retrospective study of dorsal suspension and neurectomy group. The dorsal suspension was performed by dorsal transposition of neuroma over the dorsal transverse ligament after neurolysis. The visual analog scale (VAS), the Foot and Ankle Ability Measure (FAAM), postoperative satisfaction, and complications were evaluated.ResultsBoth groups reported significant pain relief, and there were no significant differences between the groups with respect to postoperative pain. The postoperative FAAM outcomes showed no significant between-group differences. Satisfaction analysis showed ‘excellent’ and ‘good’ results in the dorsal suspension and neurectomy groups (95% and 77.7%, respectively). Complications of numbness and paresthesia reported in the dorsal suspension group (5% and 5%, respectively) were significantly fewer than those of neurectomy group (61.1% and 33.3%, respectively) (both, p < .05).ConclusionsWith its favorable results, dorsal suspension can be another operative option for the treatment of Morton’s neuroma.Level of Evidence: Level III, retrospective comparative case series. 相似文献
10.